ChemicalBook > CAS DataBase List > Benzamide, N-(4-chlorophenyl)-4-(1H-tetrazol-5-yl)-
Benzamide, N-(4-chlorophenyl)-4-(1H-tetrazol-5-yl)-
- Product Name
- Benzamide, N-(4-chlorophenyl)-4-(1H-tetrazol-5-yl)-
- CAS No.
- 651769-78-7
- Chemical Name
- Benzamide, N-(4-chlorophenyl)-4-(1H-tetrazol-5-yl)-
- Synonyms
- Xanthine oxidoreductase-IN-3;N-(4-Chlorophenyl)-4-(1H-tetrazol-5-yl)benzamide;Benzamide, N-(4-chlorophenyl)-4-(1H-tetrazol-5-yl)-
- CBNumber
- CB53250881
- Molecular Formula
- C14H10ClN5O
- Formula Weight
- 299.7151
- MOL File
- 651769-78-7.mol
More
Less
Benzamide, N-(4-chlorophenyl)-4-(1H-tetrazol-5-yl)- Chemical Properties,Usage,Production
Uses
Xanthine oxidoreductase-IN-3 is an orally active xanthine oxidoreductase (XOR) inhibitor, with an IC50 of 26.3 nM. Xanthine oxidoreductase-IN-3 can be used for the research of acute hyperuricemia[1].
in vivo
Xanthine oxidoreductase-IN-3 (compound IIIa) (5 mg/kg; p.o.) shows a uric acid-lowering effect from 3 h after administration in mice with acute hyperuricemia[1].
| Animal Model: | ICR mice (18-22 g) were induced acute hyperuricemia by injection of potassium oxonate and hypoxanthine[1] |
| Dosage: | 5 mg/kg |
| Administration: | Suspended in 0.5% CMC-Na solution for intragastric administration |
| Result: | Showed a uric acid-lowering effect from 3 h after administration. |
References
[1] Peng W, et, al. Design, synthesis, and evaluation of tricyclic compounds containing phenyl-tetrazole as XOR inhibitors. Eur J Med Chem. 2022 Nov 28;246:114947. DOI:10.1016/j.ejmech.2022.114947
Benzamide, N-(4-chlorophenyl)-4-(1H-tetrazol-5-yl)- Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Benzamide, N-(4-chlorophenyl)-4-(1H-tetrazol-5-yl)- Suppliers
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
651769-78-7, Benzamide, N-(4-chlorophenyl)-4-(1H-tetrazol-5-yl)-Related Search:
Benzamide, N-(4-ethoxyphenyl)-4-(2H-tetrazol-5-yl)-
Benzamide, N-[4-(1-methylethoxy)phenyl]-4-(2H-tetrazol-5-yl)-
Benzaldehyde, 5-fluoro-2-[[1-[(3-methoxyphenyl)methyl]-1H-1,2,3-triazol-4-yl]methoxy]-
5-Amino-1-(4-trifluoromethylphenyl)-1H-pyrazole-4-carbonitrile
Benzonitrile, 5-(2,3-dihydro-3-oxo-1H-pyrazolo[3,4-d]pyrimidin-6-yl)-2-(1-methylethoxy)-
XANTHOSINE DIHYDRATE
1H-Indole-3-carbonitrile, 1-cyclopentyl-5-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)-
Xanthyletin
Acetamide, N-(2-aminoethyl)-2-[4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-, hydrochloride (1:1)